-
Mylan acquires Abbott’s developed markets specialty & branded generics biz
Mylan has entered into a definitive agreement with Abbott whereby Mylan will acquire Abbott's non-U.S. developed markets specialty and branded generics business in an all-stock transaction.
Upon closing, Abbott will receive 105 million shares of the combined company worth approximately $5.3 billion based on Mylan's closing price of $50.20 on Friday, July 11, 2014, representing an approximately 21% ownership stake.
-
Supervalu gets first of 18 Rainbow stores ready for business
Supervalu has begun supplying the first of 18 Rainbow stores that are being acquired as part of the transactions that were announced May 7 between Roundy’s and a consortium of Supervalu and independent retailers.
Following the store conversions, Supervalu will supply all 18 of the acquired stores out of its Hopkins, Minn., distribution center.